{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:12:55Z","timestamp":1790917975579,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/inf.0b013e318199f901","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:33:20Z","timestamp":1242902000000},"page":"S89-S96","source":"Crossref","is-referenced-by-count":77,"title":["The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV\/Hib and Poliovirus Vaccines: Assessment of Immunogenicity"],"prefix":"10.1097","volume":"28","author":[{"given":"Nancy","family":"Bermal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Chrobot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison","family":"Alberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvacion","family":"Gatchalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Dieussaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1203\/00006450-199210000-00002","article-title":"Rational design of conjugate vaccines.","volume":"32","author":"Dintzis","year":"1992","journal-title":"Paediatr Res"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.","volume":"357","author":"Ramsey","year":"2001","journal-title":"Lancet"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R9-4-20210202","first-page":"31","article-title":"Pertussis vaccines WHO position paper.","volume":"80","year":"2005","journal-title":"WER"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14712598.8.4.503","article-title":"Clinical experience with DTPw-HBV and DTPw-HBV\/Hib combination vaccines.","volume":"8","author":"Prymula","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with or without 22F inhibition at low antibody concentrations in pediatric sera.","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"annex 2","key":"R16-4-20210202","first-page":"64","article-title":"Pneumococcal conjugate vaccines. Recommendations for production and control of pneumococcal conjugate vaccines.","volume":"927","year":"2005","journal-title":"WHO Tech Rep Ser"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(03)90011-7","article-title":"Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.","volume":"7","author":"Ar\u00edstegui","year":"2003","journal-title":"Int J Infect Dis"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4161\/hv.1.5.2163","article-title":"A new DTPw-HBV\/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.","volume":"1","author":"Gatchalian","year":"2005","journal-title":"Hum Vaccine"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/375242","article-title":"Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.","volume":"187","author":"Puumalainen","year":"2003","journal-title":"J Infect Dis"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.inf.0000050459.74134.d5","article-title":"Greater antibody responses to an eleven valent mixed carrier diphtheria-or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.","volume":"22","author":"Puumalainen","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.","volume":"5","author":"Hausdorff","year":"2007","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e318199f901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:42Z","timestamp":1786038642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200904001-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318199f901","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}